GRML

****Sponsored by Primetime Profiles LLC on behalf of Greenland Mines, LLC

$30 Million has been invested in theSkaergaard Project since 2000

Read The Investor Presentation HERE

Hello Everyone,

We are on a roll. That last one went crazy yesterday!

It almost broke $1 as it saw huge interest along side the company it will be merging with.

Speaking of mergers, we have a super exciting story. After Iran is done there are many who think the administration is going to focus heavy on the acquisition of Greenland. I think if the President is serious about acquiring Greenland, then that is probably what will eventually happen based on what has happened in the last 6 months.

Americans have a strong case for being bullish on Greenland because of its geostrategic position, which is arguably one of the most valuable on the planet. Greenland sits at the crossroads of North America, Europe, and the Arctic, effectively acting as a gatekeeper to the North Atlantic and emerging Arctic shipping lanes. As polar ice continues to recede, new maritime routes are opening that could reshape global trade, and Greenland is positioned right along those corridors. From a defense standpoint, it anchors the critical Greenland–Iceland–UK (GIUK) gap, a choke point used to monitor naval activity—especially from Russia—making it indispensable for U.S. and NATO security architecture. It also hosts infrastructure key to missile warning and space surveillance, reinforcing homeland defense in an era of increasingly advanced threats.

Beyond military relevance, Greenland represents a long-term economic and technological opportunity tied to the future of energy and supply chains. The island holds significant deposits of rare earth minerals and other critical resources used in everything from semiconductors to electric vehicles and renewable energy systems. As the U.S. looks to reduce dependence on foreign suppliers—particularly China—Greenland could become part of a more secure, Western-aligned resource base. At the same time, its cold climate and geographic isolation make it attractive for next-generation infrastructure like data centers and advanced computing facilities. While extraction and development remain difficult today, the strategic value lies in the optionality: as technology improves and the Arctic becomes more accessible, Greenland’s importance is likely to increase rather than diminish.

Greenland sits at the intersection of defense, trade, energy, and emerging technologies, and in a world defined by great-power competition and resource security, that combination is rare.

What is truly encouraging is that Greenland is already home to the production of Tens of thousands of ounces of gold annually.

Just over a month ago we saw Klotho Neurosciences rebrand and focus on a 2 pronged approach with the acquisition of Greenland Mines Corp who owns 80% of one of the largest and most significant undeveloped palladium, gold, and platinum deposits in the world.

Located in Southeast Greenland, the Skaergaard Project is one of the largest undeveloped gold (Au), palladium (Pd), and platinum (Pt) deposits in the world, with a total in-situ resource value of approximately $68 Billion1 at February 2026 metal prices.

Through a new drilling and development program, Greenland Mines Ltd aims to double its resource to ~50 million contained ounces of Au, Pd, and Pt, as well as adding vanadium and gallium to its raw critical metals portfolio.

The Skaergaard intrusion is recognized as one of the world's largest undeveloped resources of gold‑palladium‑platinum, with additional metals that are increasingly important to energy transition, defense application and high‑technology supply chains.

While the project area has benefitted from decades of geological, resource and academic work, historical environmental datasets are relatively limited, making the current, large‑scale baseline program a critical enabler for responsible, long‑life mine development.

Greenland Mines Secures Icebreaker Argus For 2026 Skaergaard Field Program

Ice-class vessel deployment strengthens Arctic logistics infrastructure and enables efficient execution of the 2026 Skaergaard field program

CHARLOTTE, N.C., March 25, 2026 /PRNewswire/ -- Greenland Mines Ltd. ("Greenland Mines" or the "Company") (Nasdaq: GRML) announces entry into a charter agreement with IceTugs ApS ("IceTugs") for the deployment of the icebreaker support vessel M/V Argus during the Company's 2026 field season at the Skaergaard Gold-Palladium-Platinum and Critical Metal Project in eastern Greenland.

Greenland Mines Logo (PRNewsfoto/Klotho Neurosciences, Inc.)

Under the agreement, M/V Argus will transport supplies, equipment, drill rigs, fuel, and personnel from Reykjavík, Iceland, to the Skaergaard area and adjacent fjords. It will also serve as the primary offshore logistics hub while anchored in the inner part of the deep-water sheltered fjord Mikis Fjord adjacent to the shores at Skaergaard Project and the airstrip at Sødalen for the duration of the field campaign.

The vessel will provide accommodation, marine logistics, and operational support for Greenland Mines' geological and technical programs at Skaergaard.

Greenland Mines President, Bo Møller Stensgaard, said, "Chartering M/V Argus for the 2026 field season is a major operational win for Greenland Mines. There are only a handful of vessels like this available in the North Atlantic and having a true Iceclass A1 Super icebreaker with a helideck, large accommodation capacity, and a seasoned Arctic crew dedicated to Skaergaard gives us a tremendous advantage in terms of safety, flexibility and efficiency.

"Together with our newly announced environmental baseline program, securing M/V Argus underlines how we are positioning Skaergaard on a fast, but disciplined, development track. We are encouraged at our rapid progress, putting world‑class assets and partners in place – both on the environmental side and on the operational side – as we work to unlock the full potential of this unique precious metals project in eastern Greenland."

A rare, top‑tier Arctic asset

M/V Argus is a powerful, steel offshore support and rescue vessel with Iceclass A1 Super and Polar Code compliance.  It is designed specifically as an expedition vessel and for operating safely in demanding North Atlantic and Arctic conditions, including narrow deep-water fjords along the Greenland coastline. The ship is highly maneuverable, robust and reliable, and has been modified to make the field crew for the season staying on board comfortable, with mess, office and working areas.

The vessel offers accommodation for up to approximately 40–50 persons, providing ample capacity for multi‑disciplinary field teams, logistics, contractors, and aviation personnel. M/V Argus is equipped with a certified helicopter deck and designated special aviation fuel storage, which allows integration of helicopter operations directly from the ship – a key enabler for efficient access to the Skaergaard site and surrounding region.

In addition to M/V Argus, IceTugs operates a flexible fleet of tugboats and cargo vessels tailored to Arctic logistics, providing Greenland Mines with further options to support phases of work in Greenland.

Securing M/V Argus for the 2026 season is a significant milestone, as there are very few vessels of comparable ice‑class, capacity, and Arctic track record available in the North Atlantic, and demand from expedition, science and commercial users is high.

Proven experience on Greenland's east coast

IceTugs and M/V Argus have extensive experience along the Greenland coast, including repeated voyages into East Greenland fjords for expeditions and science campaigns, as well as operations in challenging ice conditions. The captain and crew are accustomed to Arctic navigation, safety and emergency procedures, and operate in accordance with international standards for polar operations and Bureau Veritas classification requirements.

For the Skaergaard 2026 program, M/V Argus will anchor in the project, providing a stable platform for daily helicopter operations, support for drill rigs, smaller boat operations, cargo handling, and safe accommodation throughout the season. The vessel's cargo holds, deck space, and fuel/water capacity are well suited to support extended field operations and to carry additional diesel for drill rigs and onshore technical equipment and spare parts.

Enabling an efficient 2026 Skaergaard campaign

The combination of M/V Argus' icebreaking capabilities, helideck, accommodation, and cargo capacity allows Greenland Mines to execute an integrated efficient technical field program in 2026, tightly coordinated with the Company's environmental baseline work and advanced studies at Skaergaard. Operating from a single, well‑equipped Arctic vessel reduces logistical complexity, enhances safety, and maximizes productive field time for geology, environmental surveys, and technical teams.

By locking in M/V Argus early, Greenland Mines believes it has secured one of the most capable and sought‑after Arctic support vessels in the region, reinforcing the Company's commitment to safe, efficient and professional field execution as it advances Skaergaard toward an exploitation license application.

The nearby gravel airstrip at Sødalen next to Skaergaard will be used to lift in short-term topic specialists on specific technical tasks and evaluations that all will feed into the next development phase for the Project.


Greenland Mines Subsidiary Major Precious Greenland A/S Joins Greenland Business Association

Apr 2, 2026

Greenland Mines Secures Icebreaker Argus For 2026 Skaergaard Field Program

Mar 25, 2026

Greenland Mines Secures Additional 180-Day Period for Nasdaq Bid Price Compliance

Mar 23, 2026

Klotho Neurosciences Announces Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML Effective March 12, 2026

Mar 9, 2026

KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR

Mar 4, 2026

MANAGEMENT

Dr. Joseph SinkuleFounder, Chief Executive Officer (CEO), Director and Chairman of the Board

Dr. Sinkule is the company’s Chief Executive Officer (CEO), Founder, and the Chairman of the Board of Directors. He has over 40 years of drug, biologic, and medical device R&D and commercialization experience. This serial entrepreneur is the founder and driving force behind the Company, its growing product portfolio, and its financing strategies. He has personally managed over 8 drug and biotech products successfully through FDA approval to market, 5 medical devices and 8 in vitro diagnostics. He has hired and managed both small and large teams of experienced people in pharma and biotech organizations, and managed contract research organizations (“CROs”) and contract development and manufacturing companies (“CDMOs”), working for large and small clients. After serving in academics and then in industry, Dr. Sinkule has evolved into a successful businessman and entrepreneur. He serves on the Board of two companies, and routinely consults for venture capitalist firms, investment banks, as well as both large and early-stage pharmaceutical and biotech companies.

Mr. Jeffrey LeBlancChief Financial Officer

Mr. LeBlanc has over 20 years of experience in managing financial operations, investing, advising Fortune 500 companies, and launching new ventures. He is the co-founder of Winvest Acquisition Corp. (Ticker: WINV), a special purpose acquisition company. Prior to Winvest, Mr. LeBlanc launched Out of Print, a direct-to-consumer merchandise platform that was acquired by Penguin Random House in 2017. He previously served in investment roles at Greenlight Capital and GE Capital, and started his career at McKinsey and Co. Mr. LeBlanc previously served on the Boards of Riot New Media Group and Books For Africa. He received an MBA from Harvard Business School and a BS in Chemical Engineering from MIT.

Bo Møller StensgaardPresident

Bo is a seasoned executive with over 20 years in mineral exploration and natural resource development across Europe and the Arctic, starting in Greenland geology in 1998. Holding a PhD in economic geology and former Senior Research Scientist at the Geological Survey of Danmark and Greenland, he has led listed and private resource companies, advancing projects from early exploration to exploitation through technical studies, environmental/social impact assessments, permitting, and stakeholder engagement. His expertise includes listed-company leadership, international investor relations, building expert teams, and leveraging extensive networks in business, academia, politics, and the European raw materials ecosystem – gained partly from his senior advisory role at EIT RawMaterials advising on EU policy and funding. This positions him as a strong leader for Greenland Mines Corp, providing credible access to North American and European capital markets and strategic partners.

Dr. Miguel Chillón RodriguezChief Scientific Officer and Consultant

Professor Dr. Chillon is the inventor of the α-Klotho patents and technology know how. He has over 25 years of research experience in several key areas of α-klotho and adeno-associated virus (“AAV”) packaging and gene delivery. Miguel has several associates that work with him to expedite development and further the intellectual properties and scientific publications. He leads the research group on Gene therapy for CNS diseases at Universitat Autonoma De Barcelona and Institucio Catalana De Recerca I Estudis Avancats. Miguel is also the Director of the Viral Vector Production Unit at Vall d’Hebrón Hospital, and serves Chair of the ATMP Platform of European Infrastructure for Translational Medicine

Dr. Shalom HirshmanMedical Advisor and Director

Dr. Shalom Hirschman, M.D. is a preeminent research physician, a clinical medical expert, and entrepreneur in infectious diseases, oncology, and cancer supportive care. He is a key consulting advisor to the Company. As a young man, he served as an intern and resident in medicine at the Massachusetts General Hospital and Harvard Medical School, and then went on to a career in molecular biology and virology research at the National Institute of Health (NIH). During his career in medical research, he interacted closely with several Nobel Prize winners including Drs. Berson and Yalow (Nobel Prize for development of radioimmunoassays). He was recruited to The Mount Sinai School of Medicine and The Mount Sinai Hospital in New York City as Head of the Department of Infectious Diseases, and eventually he also became Vice-Chairman and Chairman of the Department of Medicine at Mount Sinai, where he remained for three decades. He still is asked to consult on difficult diagnostic dilemmas like the recent COVID-19 pandemic.

‍Sincerely,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS A PUBLICATION OF ONE22 MEDIA, LLC, HEREIN REFERRED TO AS O22. O22’S REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATIONAL PURPOSES ONLY.O22 IS ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION.
O22 HAS BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND  USD BY A THIRD PARTY, PRIMETIME PROFILES, LLC FOR A ONE DAY GRML PROFILE ON 4/14/26.
BY SUBSCRIBING TO OR OTHERWISE USING THIS WEBSITE/NEWSLETTER, YOU AGREE TO HOLD O22 AND ITS OPERATORS, OWNERS, AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS, DAMAGE, OR INJURY THAT YOU MAY INCUR, MONETARY OR OTHERWISE.
INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AN EXTREMELY HIGH DEGREE OF RISK. NEVER INVEST IN ANY STOCK FEATURED ON O22’S SITE OR NEWSLETTER UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING O22’S SERVICES, JOINING O22’S SITE OR EMAIL/BLOG LIST, OR FOLLOWING ANY SOCIAL NETWORKING PLATFORMS O22 MAY USE.
PLEASE NOTE WELL: O22 IS NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER. O22 IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES AND EXCHANGE COMMISSION, OR FINRA. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED.
THE INFORMATION CONTAINED HEREIN IS BASED ON INFORMATION SUPPLIED BY THE COMPANIES PROFILED, PUBLICLY AVAILABLE INFORMATION, PRESS RELEASES, AND OTHER SOURCES WHICH O22 BELIEVES TO BE RELIABLE, BUT IS NOT GUARANTEED BY O22 AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. O22 IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES PROFILED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE/NEWSLETTER IN DECIDING TO INVEST OR MAKE OTHER FINANCIAL DECISIONS. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE/NEWSLETTER AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. O22 STRONGLY ENCOURAGES READERS AND INVESTORS TO CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES, INCLUDING BY REVIEWING SEC FILINGS (FORMS 10-Q, 10-K, 8-K, 3, 4, 5, SCHEDULE 13D) AND BY CONSULTING YOUR OWN TAX, BUSINESS, FINANCIAL, AND INVESTMENT ADVISORS.
THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT, AND MAY BE FORWARD-LOOKING STATEMENTS. FORWARD-LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD-LOOKING STATEMENTS MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEES, EXPECTS, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, MAY, COULD, OR MIGHT. THERE IS NO GUARANTEE THAT PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS.